These are the five BPC-157 products that work, ranked by testing results, independent lab verification, and real-world effectiveness
A 2015 study by Huang and colleagues in Drug Design, Development and Therapy used a rat alkali-burn model (n=10 per group) and HUVECs treated with BPC-157 at 200800 ng/mL, reporting accelerated wound closure with enhanced granulation tissue, reepithelialization, and dermal remodeling by day 18, alongside increased endothelial migration and vascular tube formation in vitro via ERK1/2 phosphorylation though the abstract does not report numeric % wound closure or p-values
Available from, as of August 29, 2018: /CLINICAL TRIALS/ ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world
Clean the injection site with an alcohol swab
Nonsteroidal anti-inflammatory drugs, such as ibuprofen, reduce both pain and swelling
Children: Do not use